VEGFA and retinopathy of prematurity: Although existing therapies such as laser photocoagulation, vitrectomy and intravitreal injection of antibody specific for vascular endothelial growth factor have been shown to have certain effects for the attenuation of ROP progression2–4, ROP is still a leading cause of visual loss in childhood.